NDC 69097-0407-07
metoprolol succinate 50 mg/1 TABLET, EXTENDED RELEASE
Available — 2-Day Shipping
NDC
69097-0407-07
Generic Name
metoprolol succinate
Brand Name
METOPROLOL SUCCINATE
Strength
50 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
Cipla USA Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Metoprolol succinate extended-release tablets are beta-adrenergic blocker indicated for the treatment of:: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure -, to reduce the risk of cardiovascular mortality and heart failure hospitalization ins patients with heart failure ( 1.3 ) 1.1 Hypertension Metoprolo…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All metoprolol succinate Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other metoprolol succinate NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 69097-0407-07 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).